Pricing

Theriva Biologics Inc (TOVX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven A. Shallcross
Employees:
20
9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
(734) 332-7800
    Formally known as:
  • Adeona Pharmaceuticals, Inc.
  • SYNTHETIC BIOLOGICS INC
  • The Meet Kevin Pricing Power ETF-
Stock Split History
DateRatio
2007-04-25 1:3
2018-08-13 1:35
2022-07-25 1:10
Synthetic Biologics, Inc. develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade intravenous beta-lactam antibiotics in gastrointestinal (GI) tract. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available